These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 4599773)

  • 1. Immune cytolysis of human tumor cells mediated by xenogeneic "immune" RNA.
    Pilch YH; Veltman LL; Kern DH
    Arch Surg; 1974 Jul; 109(1):30-4. PubMed ID: 4599773
    [No Abstract]   [Full Text] [Related]  

  • 2. Immune cytolysis of human tumor cells mediated by xenogeneic "immune" RNA: implications for immunotherapy.
    Pilch YH; Veltman LL; Kern DH
    Surgery; 1974 Jul; 76(1):23-34. PubMed ID: 4841349
    [No Abstract]   [Full Text] [Related]  

  • 3. Immune cytolysis of murine tumor cells mediated by xenogeneic "immune" RNA.
    Kern DH; Pilch YH
    Int J Cancer; 1974 May; 13(5):679-88. PubMed ID: 4843880
    [No Abstract]   [Full Text] [Related]  

  • 4. Immune cytolysis of rat tumor cells mediated by syngeneic "immune" RNA.
    Kern DH; Drogemuller CR; Pilch YH
    J Natl Cancer Inst; 1974 Jan; 52(1):299-302. PubMed ID: 4810971
    [No Abstract]   [Full Text] [Related]  

  • 5. Immune cytolysis of human tumor cells mediated by xenogeneic "immune" ribonucleic acid: implications for immunotherapy.
    Veltman LL; Kern DH; Pilch YH
    Am J Obstet Gynecol; 1974 Aug; 119(7):959-65. PubMed ID: 4135321
    [No Abstract]   [Full Text] [Related]  

  • 6. Immune cytolysis of human tumor cells mediated by xenogeneic "immune" RNA.
    Veltman LL; Kern DH; Pilch YH
    Cell Immunol; 1974 Sep; 13(3):367-77. PubMed ID: 4476236
    [No Abstract]   [Full Text] [Related]  

  • 7. Immune cytolysis of human renal carcinoma mediated by xenogeneic immune ribonucleic acid.
    Brower PA; Dekernion JB; Ramming KP
    J Urol; 1976 Mar; 115(3):243-5. PubMed ID: 1255883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenic RNA in the immunotherapy of cancer: the transfer of antitumor cytotoxic activity and tuberculin sensitivity to human lymphocytes using xenogeneic ribonucleic acid.
    Dodd MC; Scheetz ME; Rossio JL
    Ann N Y Acad Sci; 1973 May; 207():454-67. PubMed ID: 4517721
    [No Abstract]   [Full Text] [Related]  

  • 9. In vivo and in vitro effects of xenogeneic immune ribonucleic acid in patients with advanced renal cell carcinoma: a phase I study.
    Richie JP; Wang BS; Steele GD; Wilson RE; Mannick JA
    J Urol; 1981 Jul; 126(1):24-8. PubMed ID: 6166758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mediation of immune responses to tumor antigens in vitro by immune RNA.
    Kern DH; Drogemuller CR; Pilch YH
    Ann N Y Acad Sci; 1976; 276():278-302. PubMed ID: 1071964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antigen-reactive cells to tumor antigens in normal and tumor patients.
    Falk RE; MacGregor AB
    J Surg Res; 1976 Mar; 20(3):247-53. PubMed ID: 772313
    [No Abstract]   [Full Text] [Related]  

  • 12. Kinetics of the transfer of tumor-specific cytotoxicity with immune RNA.
    Wang BS; Deckers PJ; Mannick JA
    Clin Immunol Immunopathol; 1978 Feb; 9(2):218-28. PubMed ID: 618691
    [No Abstract]   [Full Text] [Related]  

  • 13. Induction of specific cell-mediated cytoxicity in vitro by means of RNA isolated from allografted mice.
    Holán V; Lipoldová M; Zadrazil S; Hasek M
    Folia Biol (Praha); 1981; 27(6):422-6. PubMed ID: 6173268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune RNA in tumor immunology.
    Kern DH; Pilch YH
    Ann N Y Acad Sci; 1979; 332():196-206. PubMed ID: 93862
    [No Abstract]   [Full Text] [Related]  

  • 15. Immune response to a mammary adenocarcinoma. IV. Blocking of cell-mediated cytolysis by immunoglobulins binding to immune lymphocytes.
    Huber SA; Lucas ZJ
    J Immunol; 1977 Aug; 119(2):726-36. PubMed ID: 328781
    [No Abstract]   [Full Text] [Related]  

  • 16. Immunological enhancement of murine tumor isografts mediated by RNA from lymphoid organs of xenogeneic immunized animals.
    Pilch YH; Ramming KP
    Transplantation; 1971 Jan; 11(1):10-9. PubMed ID: 5549469
    [No Abstract]   [Full Text] [Related]  

  • 17. [Antibody-dependent cell-mediated cytotoxic activity by precipitating and coprecipitating rabbit, guinea pig and sheep antibodies].
    Perdigón G; Gentile T; Abatángelo C; Margni RA
    Medicina (B Aires); 1979; 39(2):178-82. PubMed ID: 502827
    [No Abstract]   [Full Text] [Related]  

  • 18. In vivo effect and parallel in vitro lymphocyte-mediated tumor cytolysis after Phase I xenogeneic immune RNA treatment of patients with widespread melanoma or metastatic renal cell carcinoma.
    Steele G; Wang BS; Richie J; Wilson RE; Ervin T; Yankee R; Fallon M; Mannick JA
    Cancer Res; 1980 Jul; 40(7):2377-82. PubMed ID: 6155992
    [No Abstract]   [Full Text] [Related]  

  • 19. Advanced renal cell carcinoma: treatment with xenogeneic immune ribonucleic acid and appropriate surgical resection.
    Skinner DG; Dekernion JB; Brower PA; Ramming KP; Pilch YH
    J Urol; 1976 Mar; 115(3):246-50. PubMed ID: 943577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mediation of cytotoxic immune responses against human tumor-associated antigens by xenogeneic immune RNA.
    Kern DH; Fritze D; Drogemuller CR; Pilch YH
    J Natl Cancer Inst; 1976 Jul; 57(1):97-103. PubMed ID: 1003510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.